JP2014509305A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509305A5
JP2014509305A5 JP2013546406A JP2013546406A JP2014509305A5 JP 2014509305 A5 JP2014509305 A5 JP 2014509305A5 JP 2013546406 A JP2013546406 A JP 2013546406A JP 2013546406 A JP2013546406 A JP 2013546406A JP 2014509305 A5 JP2014509305 A5 JP 2014509305A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
compound
subject
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013546406A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509305A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/066736 external-priority patent/WO2012092103A1/en
Publication of JP2014509305A publication Critical patent/JP2014509305A/ja
Publication of JP2014509305A5 publication Critical patent/JP2014509305A5/ja
Withdrawn legal-status Critical Current

Links

JP2013546406A 2010-12-27 2011-12-22 膵炎を治療するためのゲムカベンおよび誘導体 Withdrawn JP2014509305A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061427236P 2010-12-27 2010-12-27
US61/427,236 2010-12-27
PCT/US2011/066736 WO2012092103A1 (en) 2010-12-27 2011-12-22 Gemcabene and derivatives for treating pancreatitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015178843A Division JP6207560B2 (ja) 2010-12-27 2015-09-10 膵炎を治療するためのゲムカベンおよび誘導体

Publications (2)

Publication Number Publication Date
JP2014509305A JP2014509305A (ja) 2014-04-17
JP2014509305A5 true JP2014509305A5 (enExample) 2015-02-12

Family

ID=45498140

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013546406A Withdrawn JP2014509305A (ja) 2010-12-27 2011-12-22 膵炎を治療するためのゲムカベンおよび誘導体
JP2015178843A Active JP6207560B2 (ja) 2010-12-27 2015-09-10 膵炎を治療するためのゲムカベンおよび誘導体
JP2017169145A Pending JP2018027953A (ja) 2010-12-27 2017-09-04 膵炎を治療するためのゲムカベンおよび誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015178843A Active JP6207560B2 (ja) 2010-12-27 2015-09-10 膵炎を治療するためのゲムカベンおよび誘導体
JP2017169145A Pending JP2018027953A (ja) 2010-12-27 2017-09-04 膵炎を治療するためのゲムカベンおよび誘導体

Country Status (14)

Country Link
US (1) US8846761B2 (enExample)
EP (2) EP3170495B1 (enExample)
JP (3) JP2014509305A (enExample)
CN (2) CN107648210A (enExample)
AU (1) AU2011352449B2 (enExample)
CA (1) CA2822921C (enExample)
DK (1) DK2658536T3 (enExample)
ES (1) ES2608177T3 (enExample)
HK (1) HK1250484A1 (enExample)
HU (1) HUE031004T2 (enExample)
MX (1) MX337593B (enExample)
PL (1) PL2658536T3 (enExample)
PT (1) PT2658536T (enExample)
WO (1) WO2012092103A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015346037A1 (en) 2014-11-14 2017-07-06 Gemphire Therapeutics Inc. Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers
RU2018120599A (ru) * 2015-11-06 2019-12-09 Джемфир Терапьютикс, Инк. Лечение смешанной дислипидемии
IL269884B2 (en) 2017-04-18 2023-09-01 Gemphire Therapeutics Inc Gamkaban its accepted pharmaceutical salts, their compositions and methods of their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0369035A4 (en) * 1988-06-06 1991-07-17 Showa Denko Kabushiki Kaisha Agent for treating pancreatitis or the like
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
US20030105154A1 (en) * 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
US20020103252A1 (en) 1997-12-12 2002-08-01 Bisgaier Charles Larry Statin-carboxyalkylether combinations
MXPA01009893A (es) 1999-04-01 2003-07-28 Esperion Therapeutics Inc Compuestos con eter, composiciones y usos de estos.
MXPA03003021A (es) * 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
US6645170B2 (en) 2001-03-05 2003-11-11 Bioject Medical Technologies, Inc. Simplified disposable needle-free injection apparatus and method
US20040229954A1 (en) * 2003-05-16 2004-11-18 Macdougall Diane Elaine Selective manipulation of triglyceride, HDL and LDL parameters with 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt
US7345190B2 (en) 2003-11-12 2008-03-18 Ssv Therapeutics, Inc. Carnitine conjugates as dual prodrugs and uses thereof

Similar Documents

Publication Publication Date Title
CA2861643C (en) Methods of reducing risk of cardiovascular disease
JP2010077141A5 (enExample)
JP2017505285A5 (enExample)
ES2752039T3 (es) Agente terapéutico para la dislipidemia
JP2012097105A5 (enExample)
JP2017513836A5 (enExample)
JP2013500986A5 (enExample)
RU2013121788A (ru) Ингибиторы репликации вич
JP2009530398A5 (enExample)
SG10201407013QA (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
JP2012525393A5 (enExample)
JP2013542247A5 (enExample)
NZ743706A (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
JP2017508817A5 (enExample)
JP2018538273A5 (enExample)
JP2014505017A5 (enExample)
JP2015509075A5 (enExample)
EA201270071A1 (ru) Способ лечения пациента, нуждающегося в аспириновой терапии
JP2014515407A5 (enExample)
JP2011046708A5 (enExample)
JP2013513607A5 (enExample)
JP2012505905A5 (enExample)
JP2014509305A5 (enExample)
RU2015127834A (ru) Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина
JP2014503589A5 (enExample)